BioCardia, Inc. (BCDA) dividend history

BCDANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30

$0.83−0.10 (-10.38%)

Close on Nov 12, 2026Market cap $12.50MP/E –Yield –

Dividends

BioCardia has not reported a dividend

No dividend per share appears in BioCardia's annual filings since fiscal 2010.

Where these numbers come from

Parsed from the XBRL in BioCardia's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-15 reverse split on May 30, 2024
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is BCDA.

Compare: BCDA vs CELZ · BCDA vs ALLO · BCDA vs SNTI · BCDA vs TLPH · BCDA vs TCRT

Revenue growth-100.0% · median -50.0%

Company	Revenue	Growth
CELZ	$3.00K	-50.0%
TCRT	$3.00K	-50.0%
BCDA	$0	-100.0%
ALLO	–	–
SNTI	–	–
TLPH	$0	-100.0%

Company

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
Fiscal year ends: December 31
Employees: 21
Held by institutions: 8.8%
Auditor: PKF San Diego, LLP
SEC CIK: 925741

Advertisement
300 × 250

See a number that looks wrong?